Triple receptor agonist
GIP + GLP-1 + glucagon balanced activity.
FOR RESEARCH PURPOSES ONLY — This compound is not FDA approved. All data presented is from peer-reviewed literature for educational reference.
Metabolic Peptide
GLP-3
- Retatrutide
- LY3437943
- GIP/GLP-1/Glucagon Tri-Agonist
A 39-residue triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors — used as a research compound in metabolic and incretin-signaling studies.
$130.00
Janoshik batch COA · independent verify link · USA warehouse shipping
- Janoshik batch COAs
- Free shipping on $250+
- Shipment + damage protection
- 256-bit SSL checkout
GLP-3 · $130.00
39-residue design
Stabilized backbone characterized in published research literature.
99%+ identity purity
HPLC + MS verified per batch. CoA included.
What Is GLP-3?
GLP-3 (LY3437943) is a 39-amino-acid synthetic peptide engineered for balanced agonism at the gastric inhibitory polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors. Vorix Labs supplies GLP-3 as a research catalog item with Janoshik Analytical batch CoA documentation and USA warehouse fulfillment. Laboratory / in-vitro use only — not for human or veterinary use.
GLP-3 (LY3437943) is a 39-amino-acid synthetic peptide engineered for balanced agonism at the gastric inhibitory polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors. Characterized in preclinical and clinical research literature exploring integrated multi-receptor signaling.
Researchers searching for GLP-3, Retatrutide, or LY3437943 typically need a documented triple-agonist reagent for metabolic and incretin-pathway assays. Vorix Labs supplies lyophilized GLP-3 with batch-level identity testing so protocols can cite purity and lot data. Common lab search terms this page targets include “buy Retatrutide research peptide,” “GLP-3 for sale,” and “LY3437943 CoA.” Material is intended strictly for controlled laboratory use — not for clinical or consumer applications.
Technical specifications
Type
Synthetic 39-residue triagonist peptide
Molecular weight
~4,900 g/mol
Appearance
White lyophilized powder
Identity purity
≥ 99% (HPLC + MS)
GLP-3 — common research questions
Straight answers for researchers comparing purity, CoA documentation, kits, and shipping.
Is GLP-3 for research use only?
Yes. GLP-3 from Vorix Labs is sold strictly for laboratory / in vitro research. It is not for human or veterinary use and is not evaluated by the U.S. FDA for any clinical purpose.
Do you provide a Certificate of Analysis for GLP-3?
Every Vorix batch is identity-verified with a Janoshik Analytical Certificate of Analysis (CoA). CoA access is available on the product page and through our CoA library for researchers who need batch documentation.
Can I buy GLP-3 as a single vial or a kit of 10?
Yes. Most catalog SKUs offer a single vial and a kit-of-10 option with kit pricing when inventory supports a full kit. Select the package size on the product page before adding to cart.
Where does Vorix Labs ship GLP-3 from?
Orders ship from our USA warehouse with domestic fulfillment. Standard shipping is free on qualifying orders of $250+.
Is GLP-3 the same as Retatrutide?
GLP-3 is the catalog name Vorix uses for the research peptide commonly referenced as Retatrutide (LY3437943) — a 39-residue multi-receptor agonist studied in published metabolic research literature.
Browse the full research peptide catalog · pair lyophilized vials with bacteriostatic water · Janoshik CoA library
Peer-reviewed research
- N Engl J MedTriple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial
- LancetRetatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial
Frequently researched together
IMPORTANT RESEARCH NOTICE
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.